In this week’s Innovation Partners BioBlog, all eyes are on the pharmaceutical industry. The new Medicare coverage rules for CAR-T therapy may pave the way for adoption of more slow-growing meds. The FDA weighs criminal and civil charges against a subsidiary of Novartis for falsely reporting data. Meanwhile, Anthem’s PBM IngenioRx appears to be on ...

In this week’s Innovation Partners BioBlog, we look at the many changes and updates in the pharmaceutical world. The Senate’s drug pricing provision is raising alarms for some doctors. Canadian hospitals face a shortage of critical chemotherapy drugs. Eli Lilly’s CEO pushed back at Democratic party candidates’ proposals to cap drug prices. CVS announced a ...

This week in the Innovation Partners BioBlog, Pfizer and Mylan are rumored to be closing a deal that would merge Upjohn with Myland to focus on low-priced drugs. Merck takes another step on the road to immunotherapy treatment for breast cancer. The Trump administration continues its quest for hospital pricing transparency to empower consumers, and ...

Democrat Nancy Pelosi announced that the proposed bill from the Democrats to lower drug prices is ready but won’t be unveiled until September. Anthem plans to launch a new health app with a trial rollout in Indiana before national rollout. UnitedHealth published a study examining the costs of visiting a hospital emergency department, urgent care ...

This week’s Innovation Partners BioBlog focuses on the top stories from the oncology sector. GSK announced trial results in its promising ovarian cancer drug, while AbbieVie scooped up Mavpharma to enhance its early stage oncology pipeline. The Trump Administration shot down the drug rebate rule, and much more in this week’s BioBlog. GSK's Zejula racks ...

Drugmakers breathed a sigh of relief when the courts decided against the HHS rule that television ads would be required to include the price of a 30-day supply of the advertised drug. President Trump indicated he would make a move to help the USA pay similar prices to other nations for drug coverage. A new ...

In this week’s Innovation Partners BioBlog, we look at several top stories from around the world. New evidence shows that the Affordable Care Act improved cardiac patients’ access thanks to Medicaid expansion. Three states plan to import drugs from Canada where costs for prescription medicines are cheaper. And while the recent furor (and lawsuits) about ...

The United States Supreme Court has agreed to hear the suit against the government in which insurers claim the government backed out of its agreed corridor payments to offset losses from participation in Obamacare markets by initiating a cap against payments. President Trump has signed an executive order requiring hospitals to list “shoppable” prices in ...

As the presidential election draws ever nearer, the debate over how to address the rising cost of prescription drugs and provide healthcare coverage for all continues to rage. President Trump plans to unveil his healthcare plan soon. Governor Abbott of Texas has signed into law a measure to prevent ‘surprise billing.’ This and more are ...

This week’s Innovation Partners BioBlog offers unique perspectives on the issues facing the healthcare industry today. Some CEOs, for example, believe that a “Medicare for all” type of health insurance system would improve the economy by decoupling health insurance from the cost of hiring workers. Other perspectives include an interview with FDA Director Janet Woodcock, ...